| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
ID: ALA109103
Max Phase: Preclinical
Molecular Formula: C30H35N3O8
Molecular Weight: 505.57
Molecule Type: Small molecule
Associated Items:
Representations
Canonical SMILES: CC(=O)O.CCC1(O)C(=O)OCc2c1cc1n(c2=O)Cc2c-1nc1cc3c(cc1c2CCNCC(C)C)OCCO3
Standard InChI: InChI=1S/C28H31N3O6.C2H4O2/c1-4-28(34)20-10-22-25-18(13-31(22)26(32)19(20)14-37-27(28)33)16(5-6-29-12-15(2)3)17-9-23-24(11-21(17)30-25)36-8-7-35-23;1-2(3)4/h9-11,15,29,34H,4-8,12-14H2,1-3H3;1H3,(H,3,4)
Standard InChI Key: IEUPDVVCFRQRGD-UHFFFAOYSA-N
Associated Targets(Human)
A549 127892 Activities
DLD-1 17511 Activities
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
HEC-1B cell line 31 Activities
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
Caov-3 cell line 328 Activities
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
KATO III stomach cancer cell line 114 Activities
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
Molecule Features
| Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
| Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
| Chirality: No | Availability: No | Prodrug: No |
Drug Indications
| MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
|---|
Mechanisms of Action
| Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
|---|
Properties
| Molecular Weight: 505.57 | Molecular Weight (Monoisotopic): 505.2213 | AlogP: 2.64 | #Rotatable Bonds: 6 |
| Polar Surface Area: 111.91 | Molecular Species: BASE | HBA: 9 | HBD: 2 |
| #RO5 Violations: 1 | HBA (Lipinski): 9 | HBD (Lipinski): 2 | #RO5 Violations (Lipinski): 1 |
| CX Acidic pKa: 11.74 | CX Basic pKa: 10.45 | CX LogP: 1.63 | CX LogD: -1.02 |
| Aromatic Rings: 3 | Heavy Atoms: 37 | QED Weighted: 0.30 | Np Likeness Score: 0.62 |
References
| 1. Jew S, Kim HJ, Kim MG, Roh EY, Hong CI, Kim JK, Lee JH, Lee H, Park H.. (1999) Synthesis and in vitro cytotoxicity of hexacyclic camptothecin analogues., 9 (22): [PMID:10576688] [10.1016/s0960-894x(99)00555-7] |
Source
Source(1):